Development Implementation


Ideally, following the process of preparing a Japanese development strategy, gaining the advocacy of Japanese KOLs, and obtaining regulatory endorsement of a detailed development plan, companies should be able to maintain development momentum by implementing and managing trials until the completion of partnering negotiations. However, Japanese CROs, for the most part, do not have the high level, multi-disciplinary expertise required to manage drug development.

IDA's expert team fills this niche and offers the skills required to manage the medical, regulatory, operational, and legal complexities of drug development in a fully bilingual, bicultural, and transparent manner, thus enabling companies without a presence to truly enhance product value.